Overview

A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function

Status:
NOT_YET_RECRUITING
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to help determine the right dose of LY3537982 in participants with kidney problems, particularly those with severe kidney problems. The study will last about 43 days for each participant.
Phase:
PHASE1
Details
Lead Sponsor:
Eli Lilly and Company